Prostaglandin D2 Selectively Induces Chemotaxis in T Helper Type 2 Cells, Eosinophils, and Basophils via Seven-Transmembrane Receptor Crth2

Prostaglandin (PG)D2, which has long been implicated in allergic diseases, is currently considered to elicit its biological actions through the DP receptor (DP). Involvement of DP in the formation of allergic asthma was recently demonstrated with DP-deficient mice. However, proinflammatory functions of PGD2 cannot be explained by DP alone. We show here that a seven-transmembrane receptor, CRTH2, which is preferentially expressed in T helper type 2 (Th2) cells, eosinophils, and basophils in humans, serves as the novel receptor for PGD2. In response to PGD2, CRTH2 induces intracellular Ca2+ mobilization and chemotaxis in Th2 cells in a Gαi-dependent manner. In addition, CRTH2, but not DP, mediates PGD2-dependent cell migration of blood eosinophils and basophils. Thus, PGD2 is likely involved in multiple aspects of allergic inflammation through its dual receptor systems, DP and CRTH2.

[1]  Takao Shimizu,et al.  A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders. , 2000, The Journal of experimental medicine.

[2]  S. Narumiya,et al.  Prostaglandin D2 as a mediator of allergic asthma. , 2000, Science.

[3]  L. Cosmi,et al.  CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2 T cytotoxic cells in health and disease. , 2000, European journal of immunology.

[4]  K. Sugamura,et al.  CRTH2, an orphan receptor of T‐helper‐2‐cells, is expressed on basophils and eosinophils and responds to mast cell‐derived factor(s) , 1999, FEBS letters.

[5]  K. Sugamura,et al.  Selective expression of a novel surface molecule by human Th2 cells in vivo. , 1999, Journal of immunology.

[6]  S. Narumiya,et al.  Prostanoid receptors: structures, properties, and functions. , 1999, Physiological reviews.

[7]  K. Matsushima,et al.  Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. , 1999, International immunology.

[8]  C. Mackay,et al.  Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. , 1998, Immunology today.

[9]  A. Ford-hutchinson,et al.  Characterization of the recombinant human prostanoid DP receptor and identification of L‐644,698, a novel selective DP agonist , 1998, British journal of pharmacology.

[10]  L. Roberts,et al.  Effects of a selective DP receptor agonist (BW 245C) and antagonist (BW A868C) on the canine colonic epithelium: an argument for a different DP receptor? , 1995, The Journal of pharmacology and experimental therapeutics.

[11]  Y. Boie,et al.  Molecular Cloning and Characterization of the Human Prostanoid DP Receptor (*) , 1995, The Journal of Biological Chemistry.

[12]  C. Serhan,et al.  Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor , 1994, The Journal of experimental medicine.

[13]  P. Allavena,et al.  Vasodilation in multistep paradigm of leucocyte extravasation , 1994, The Lancet.

[14]  T. Springer.  Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm , 1994, Cell.

[15]  P. Murphy.  The molecular biology of leukocyte chemoattractant receptors. , 1994, Annual review of immunology.

[16]  P. Rangachari,et al.  Biological activity of metabolites of PGD2 on canine proximal colon. , 1993, The American journal of physiology.

[17]  S. Durham,et al.  Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. , 1992, The New England journal of medicine.

[18]  D. Woodward,et al.  Studies on the ocular pharmacology of prostaglandin D2. , 1990, Investigative ophthalmology & visual science.

[19]  D. Millar,et al.  Prostaglandin D2 modulates human neutrophil intracellular calcium flux and inhibits superoxide release via its ring carbonyl. , 1990, Life sciences.

[20]  J. Nadel,et al.  Prostaglandin D2 causes accumulation of eosinophils in the lumen of the dog trachea. , 1989, Journal of applied physiology.

[21]  A. Kagey‐Sobotka,et al.  Cutaneous late-phase response to allergen. Mediator release and inflammatory cell infiltration. , 1989, The Journal of clinical investigation.

[22]  P. Leff,et al.  The biology and pharmacology of PGD2. , 1988, Prostaglandins.

[23]  S. Narumiya,et al.  Different responsiveness of prostaglandin D2‐sensitive systems to prostaglandin D2 and its analogues , 1985, British journal of pharmacology.

[24]  T. Moore,et al.  Mediators of inflammation. , 1985, Seminars in arthritis and rheumatism.

[25]  O. Hayaishi,et al.  Specific binding of prostaglandin D2 to rat brain synaptic membrane. Occurrence, properties, and distribution. , 1982, The Journal of biological chemistry.

[26]  J. Oates,et al.  Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. , 1982, Journal of immunology.